apricus wealth, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
apricus wealth, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$239,822
+9.2%
77,362
+0.0%
0.21%
+8.8%
Q2 2023$219,614
+25.7%
77,3290.0%0.19%
+21.4%
Q1 2023$174,764
-35.2%
77,3290.0%0.16%
-35.4%
Q4 2022$269,878
-93.2%
77,329
-28.0%
0.25%
-93.8%
Q3 2022$3,973,000
+527.6%
107,329
+222.0%
3.94%
+581.3%
Q2 2022$633,000
-28.5%
33,334
-1.8%
0.58%
-19.8%
Q1 2022$885,000
+15.7%
33,9340.0%0.72%
+5.7%
Q4 2021$765,00033,9340.68%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders